Cargando…
Analysis of the Protective Efficacy of Approved COVID-19 Vaccines Against Various Mutants
The outbreak of COVID-19 (caused by SARS-CoV-2) has posed a significant threat to global public health security because of its high pathogenicity and infectivity. To date, the pathogenic mechanism of this novel coronavirus (SARS-CoV-2) is still unclear, and there is no effective treatment. As one of...
Autores principales: | Li, Chaonan, Guo, Yikai, Fang, Zhongbiao, Zhang, Haiyan, Zhang, Yanjun, Chen, Keda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095899/ https://www.ncbi.nlm.nih.gov/pubmed/35572594 http://dx.doi.org/10.3389/fimmu.2022.804945 |
Ejemplares similares
-
Application of bioreactor technology for cell culture-based viral vaccine production: Present status and future prospects
por: Fang, Zhongbiao, et al.
Publicado: (2022) -
Adenovirus Vaccine Containing Truncated SARS-CoV-2 Spike Protein S1 Subunit Leads to a Specific Immune Response in Mice
por: Chen, Keda, et al.
Publicado: (2023) -
Kinetics of severe acute respiratory syndrome coronavirus 2 infection antibody responses
por: Lin, Yajie, et al.
Publicado: (2022) -
An updated review of SARS‐CoV‐2 detection methods in the context of a novel coronavirus pandemic
por: Zhang, Yuxuan, et al.
Publicado: (2022) -
Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development
por: Chen, Keda, et al.
Publicado: (2021)